Objective To assess the efficacy of etanercept in the treatment of early active nonsteroidal
antiinflammatory drug (NSAID)–refractory nonradiographic axial spondyloarthritis (SpA). …

Background: Many elderly female residents of long-term care facilities have osteoporosis
and could benefit from intervention to increase bone density. Objective: To examine the …

Objective To evaluate the efficacy and safety of etanercept (ETN) after 48 weeks in patients
with early active non-radiographic axial spondyloarthritis (nr-axSpA). Methods Patients …

Objective To compare 2 years of radiographic sacroiliac joint (SIJ) changes in patients with
recent onset axial spondyloarthritis (axSpA) receiving etanercept in a clinical trial (EMBARK) …

Objective To evaluate the long‐term clinical and imaging efficacy of etanercept in patients
with early, active nonradiographic axial spondyloarthritis (SpA). Methods Adult patients who …

Objective. Analyses were conducted to examine the baseline burden of illness and compare
the effect of etanercept (ETN) versus placebo (PBO) on quality of life (QOL) in patients with …

Safety and Efficacy Of Etanercept In Early Non-Radiographic Axial Spondyloarthritis: A
Randomized, Double-Blind, Placebo-Controlled Trial At 24 Weeks | Scholarly Publications Skip …

Clinical and Imaging Efficacy of Etanercept in Early Non-Radiographic Axial
Spondyloarthritis: 104-Week Treatment Results | Scholarly Publications Skip to main …

Clinical and Imaging Efficacy of Etanercept in Early Non-radiographic Axial Spondyloarthritis;
48-Week Treatment Data | Scholarly Publications Skip to main content Universiteit Leiden …

Better Health-Related Quality of Life and Work Capacity in Patients Achieving Inactive Disease
and Clinical Response in Patients with Non-Radiographic Axial Spondyloarthritis | Scholarly …